Overall survival according to LCT genotype. The impact of the donor LCT-13910C > T polymorphism is not dependent on diagnosis, myeloablative conditioning, or type of donor. It is seen in AML patients who received a transplantation after myeloablative conditioning from HLA-identical sibling donors (A), as well as in all other patients (B).